7-Methoxytryptamine | CAS 2436-04-6 - Request Quote
7-Methoxytryptamine
| SZ CAT No: | SZ-M079016 |
| CAS No | 2436-04-6 |
| Mol.F. | C11H14N2O |
| Mol.Wt. | 190.2 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 112496-59-0 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
7-Methoxytryptamine is chemically 2-(7-Methoxy-1H-indol-3-yl)ethan-1-amine. 7-Methoxytryptamine is supplied with detailed characterization data compliant with regulatory guideline. 7-Methoxytryptamine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Melatonin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2436-04-6
Purchase 2436-04-6
Order 2436-04-6
Enquire 2436-04-6
price of 2436-04-6
2436-04-6 Supplier
2436-04-6 Manufacturer
2436-04-6 Exporter
buy high quality 7-Methoxytryptamine
Purchase 7-Methoxytryptamine
7-Methoxytryptamine suppliers
7-Methoxytryptamine manufacturers
7-Methoxytryptamine price
Order 7-Methoxytryptamine
Enquire 7-Methoxytryptamine
7-Methoxytryptamine cost
7-Methoxytryptamine Supplier
7-Methoxytryptamine Distributor
7-Methoxytryptamine for Method Validation
Melatonin Reference Standard
7-Methoxytryptamine for ANDA Filing
7-Methoxytryptamine for Forced Degradation Studies
7-Methoxytryptamine Identification Standards
7-Methoxytryptamine for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


